1.Than NN et al. A concise review of non-alcoholic fatty liver disease. Atherosclerosis. 2015 Mar; 239(1): 192-202
2.Keating SE et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatology. 2015 Apr 1.
3.Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic fatty liver disease: a randomized controlled pilot study. Hepat Mon. 2012 Aug; 12(8):e6099
4.Dyson JK et al. Non-alcoholic fatty liver disease: a practical approach to treatment. Postgrad med J. 2015 Feb;91(1072):92-101
5.C.F. et al. Silymarin in non-alcoholic fatty liver disease. World J Hepatol. 2013 Mar 27; 5(3):109-13
6.E.T. et al. Recent advances in dietary supplementation in treating non-alcoholic fatty liver disease. World J Hepatol. 2015 Feb 27; 7(2):204-12
7.Miele L. et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009 Jun;49(6):1877-87